Once considered stodgy and boring, dividend-paying stocks were used mostly to protect an investor’s portfolio. The regular cash payout helped to balance out losses from other holdings. But these companies took on new meaning after the 2008 crash, at least for Cramer.

Moody's Investors Service issued a negative opinion on the pharmaceutical industry Thursday, saying drugmaker credit ratings will be under pressure until early 2012 because they won't be able to fully replace revenue from best-sellers that go off-patent.

A former pharmaceutical company executive who returned to Kansas this year announced Tuesday that he's running for governor, giving Democrats a declared candidate.

Drugmakers, Internet companies and nonprofits packed a hearing Thursday into what is a gray area for U.S. health regulators: how far social media can go in promoting drugs.

WASHINGTON (Reuters)- Drug makers, Internet companies and nonprofits packed a hearing into what is a gray area for U.S. health regulators: how far Twitter, Wikipedia, blogs and other social media can go in promoting drugs.

A new study shows that a diabetes treatment awaiting FDA approval may also work as a weightloss drug.

Stocks finished lower after well-known banking analyst Dick Bove downgraded his rating on Wells Fargo.

Stocks advanced Wednesday as investors were encouraged by a few earnings reports, including Morgan Stanley, Yahoo and SanDisk. The VIX, widely considered the best gauge of fear in the market, dropped to just above 20.

Stocks opened lower Wednesday as a raft of companies beating earning estimates but failed to impress investors.

Earnings season continues in earnest Wednesday, as we roll on with a week that will ultimately see 25 percent of the S&P 500 report their quarterly numbers. 

Drugmaker Eli Lilly & Co says it will eliminate thousands of jobs and reorganize into five business units in an effort to slash costs and speed up development of potential new drugs.

Pfizer Inc. was slapped this week with a record $2.3 billion in fines for illegally marketing some drugs, but critics say even that eye-popping total is unlikely to end the practice.

Virtually every large pharmaceutical company seems to have discovered cancer, and a substantial portion of the smaller biotechnology companies are focused on it as well. Together, the companies are pouring billions of dollars into developing cancer drugs.

Use of antidepressant drugs in the United States doubled between 1996 and 2005, probably because of a mix of factors, researchers reported on Monday.

The Dow and S&P snapped their winning streaks Wednesday as disappointing earnings from two of Wall Street's biggest names overshadowed another round of earnings beats.